Forge Biologics to Participate in Upcoming Investor Conferences and Presentations in March 2022

Designing for the Future of Cell and Gene Therapy Facilities

44 Thriving Biotech Startups (2021)





Current and Future Prospects for Gene Therapy for Rare Genetic Diseases Affecting the Brain and Spinal Cord





Solid Biosciences, Forge Biologics Enter Development and Manufacturing Pact





EMA Orphan Drug Designation for Forge Biologics’ gene therapy for Krabbe disease


VIDEO: Manufacturing Capabilities

